GNMX
Aevi Genomic Medicine, Inc.
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
54 hedge funds and large institutions have $38M invested in Aevi Genomic Medicine, Inc. in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 10 closing their positions.
Holders
54
Holders Change
+11
Holders Change %
+25.58%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
19
Reduced
6
Closed
10
Calls
$62K
Puts
$79K
Net Calls
-$17K
Net Calls Change
-$74K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Acadian Asset Management
Boston,
Massachusetts
| $4K | +$4K | +711 | New |
|
52
Bank of America
Charlotte,
North Carolina
| $3K | +$3K | +460 | New |
|
|
TDC
53
Thompson Davis & Co
Richmond,
Virginia
| $2K | – | – | – |
|
54
Barclays
London,
United Kingdom
| $2K | +$2K | +322 | New |
|
|
SFM
55
Sphera Funds Management
Tel Aviv,
Israel
| – | -$1.41M | -175,000 | Closed |
|
56
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$338K | -41,923 | Closed |
|
|
CS
57
Credit Suisse
Zurich,
Switzerland
| – | -$314K | -38,992 | Closed |
|
|
EEG
58
E.E. Geduld
| – | -$262K | -32,500 | Closed |
|
59
Millennium Management
New York
| – | -$194K | -24,108 | Closed |
|
60
Goldman Sachs
New York
| – | -$176K | -21,862 | Closed |
|
|
SIM
61
Spark Investment Management
New York
| – | -$124K | -15,400 | Closed |
|
|
BCM
62
BlueCrest Capital Management
St Helier,
Jersey
| – | -$120K | -14,901 | Closed |
|
|
ICM
63
Ionic Capital Management
New York
| – | -$60K | -7,500 | Closed |
|
64
Creative Planning
Overland Park,
Kansas
| – | -$8K | -940 | Closed |
|